Home Cart Sign in  
Chemical Structure| 452342-67-5 Chemical Structure| 452342-67-5

Structure of GW788388
CAS No.: 452342-67-5

Chemical Structure| 452342-67-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GW788388 is a potent and selective inhibitor of ALK5 with an IC50 of 18 nM, and also inhibits TGF-β type II receptor and activin type II receptor activities, without affecting BMP type II receptor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GW788388

CAS No. :452342-67-5
Formula : C25H23N5O2
M.W : 425.48
SMILES Code : O=C(NC1CCOCC1)C1=CC=C(C=C1)C1=NC=CC(=C1)C1=CNN=C1C1=NC=CC=C1
MDL No. :MFCD16038936
InChI Key :SAGZIBJAQGBRQA-UHFFFAOYSA-N
Pubchem ID :10202642

Safety of GW788388

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • TGFβRI/ALK5

    ALK5, IC50:18 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HT-22 cells 1 μM 24 hours To investigate the effect of GW788388 on CCL2 and CX3CL1 expression in HT-22 cells. Results showed that GW788388 significantly inhibited TGF β1-induced increase in CCL2 expression and decrease in CX3CL1 expression. PMC6446280
Macrophages 0.5–2μM 48 hours Inhibition of TGF-β1 signaling, reduction in viral load. PMC9544077
iPSC-derived renal proximal tubular-like cells (PTL) 1 μM 1 to 24 hours GW788388 did not induce any genes within the stress response pathways but showed deregulation of genes involved in TGFβ inhibition, including down-regulation of CYP24A1 and SERPINE1 and upregulation of WT1. PMC10425493
Human Peritoneal Mesothelial Cells (HPMCs) 1, 5, 10 μM 24–72 hours GW788388 attenuated TGF-β-induced morphological changes and reversed TGF-β-mediated changes in epithelial or mesenchymal markers. PMC8124410

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Permanent distal middle cerebral artery occlusion (DMCAO) model Subcutaneous injection 10 nmol every 3 days for several weeks To evaluate the effects of GW788388 on motor function, reactive gliosis, and perivascular CSF distribution after DMCAO. Results showed that GW788388 treatment significantly improved motor function, reduced reactive gliosis, and restored perivascular CSF distribution. PMC6885082
C57/BL6 mice Peritoneal fibrosis model Oral gavage 0.2 mmol Gd/kg Once 1 day before and once 7 days after GW788388 improved peritoneal thickness and fibrosis, and recovered peritoneal membrane function in a peritoneal fibrosis mouse model. PMC8124410

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.23mL

11.75mL

2.35mL

1.18mL

23.50mL

4.70mL

2.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories